Skip to main content
. 2023 Feb 17;46(4):801–810. doi: 10.2337/dc22-1889

Figure 2.

Figure 2

Change in UACR by subgroup analyses. Data are for the trial product estimand (assesses treatment effect if all patients adhered to treatment without rescue intervention) unless otherwise stated. RI, renal impairment; SBP, systolic blood pressure; SGLT2i, SGLT2 inhibitor.